Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Moltzen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Hospital & Community Psychiatry|November 1, 1986
The psychiatric health facility: an alternative for acute inpatient treatment in a nonhospital settingS Moltzen, H Gurevitz, M Rappaport, et al.
Hospital & Community Psychiatry|November 1, 1984
Mobile medical screening teams for public programsL M Koran, S Moltzen, H C Sox, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 30, 1998
Lu 25-109, a combined m1 agonist and m2 antagonist, modulates regulated processing of the amyloid precursor protein of Alzheimer's diseaseD Müller, H Wiegmann, U Langer, et al.
Psychopharmacology|July 31, 1998
In vivo muscarinic cholinergic mediated effects of Lu 25-109, a M1 agonist and M2/M3 antagonist in vitroC Sánchez, J Arnt, M Didriksen, et al.
Hospital & Community Psychiatry|October 1, 1987
A method for comparing two systems of acute 24-hour psychiatric careM Rappaport, H Goldman, P Thornton, et al.
Archives of General Psychiatry|August 1, 1989
Medical evaluation of psychiatric patients. I. Results in a state mental health systemL M Koran, H C Sox, K I Marton, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Hospital & Community Psychiatry|November 1, 1986
The psychiatric health facility: an alternative for acute inpatient treatment in a nonhospital settingS Moltzen, H Gurevitz, M Rappaport, et al.
Hospital & Community Psychiatry|November 1, 1984
Mobile medical screening teams for public programsL M Koran, S Moltzen, H C Sox, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 30, 1998
Lu 25-109, a combined m1 agonist and m2 antagonist, modulates regulated processing of the amyloid precursor protein of Alzheimer's diseaseD Müller, H Wiegmann, U Langer, et al.
Psychopharmacology|July 31, 1998
In vivo muscarinic cholinergic mediated effects of Lu 25-109, a M1 agonist and M2/M3 antagonist in vitroC Sánchez, J Arnt, M Didriksen, et al.
Hospital & Community Psychiatry|October 1, 1987
A method for comparing two systems of acute 24-hour psychiatric careM Rappaport, H Goldman, P Thornton, et al.
Archives of General Psychiatry|August 1, 1989
Medical evaluation of psychiatric patients. I. Results in a state mental health systemL M Koran, H C Sox, K I Marton, et al.
Pageof 1